Evidence map›Paper›PMID 33374315›Full record

ReviewDiagnostics (Basel, Switzerland)2020

Bringing Data Analytics to the Design of Optimized Diagnostic Networks in Low- and Middle-Income Countries: Process, Terms and Definitions.

Kameko Nichols, Sarah J Girdwood, Andrew Inglis, Pascale Ondoa, Karla Therese L Sy, Mariet Benade, Aloysius Bingi Tusiime, Kekeletso Kao, Sergio Carmona, Heidi Albert and 1 more

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. A Generalizable Decision-Making Framework for Selecting Onsite versus Send-out Clinical Laboratory Testing.Medical decision making : an international journal of the Society for Medical Decision Making · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kameko NicholsFIND, 1202 Geneva, Switzerland.
Sarah J GirdwoodHealth Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.ORCID 0000-0002-8492-028X
Andrew InglisUSAID Global Health Supply Chain Programme, Procurement and Supply Management, International Business Machines, Arlington, VA 22202, USA.
Pascale OndoaAfrican Society for Laboratory Medicine, Addis Ababa 5487, Ethiopia.
Karla Therese L SyDepartment of Global Health, Boston University School of Public Health, Boston, MA 02118, USA.ORCID 0000-0003-0608-9811
Mariet BenadeDepartment of Global Health, Boston University School of Public Health, Boston, MA 02118, USA.ORCID 0000-0001-9498-3199
Aloysius Bingi TusiimeUSAID Global Health Supply Chain Programme, Procurement and Supply Management, Chemonics International, Arlington, VA 22202, USA.ORCID 0000-0002-0973-3134
Kekeletso KaoFIND, 1202 Geneva, Switzerland.
Sergio CarmonaFIND, 1202 Geneva, Switzerland.
Heidi AlbertFIND, Cape Town 7925, South Africa.ORCID 0000-0002-8595-4123
Brooke E NicholsHealth Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.ORCID 0000-0003-4682-4999

Funding

Bill and Melinda Gates Foundation OPP1203377
6 · The paper itself

Abstract

Diagnostics services are an essential component of healthcare systems, advancing universal health coverage and ensuring global health security, but are often unavailable or under-resourced in low- and middle-income (LMIC) countries. Typically, diagnostics are delivered at various tiers of the laboratory network based on population needs, and resource and infrastructure constraints. A diagnostic network additionally incorporates screening and includes point-of-care testing that may occur outside of a laboratory in the community and clinic settings; it also emphasizes the importance of supportive network elements, including specimen referral systems, as being critical for the functioning of the diagnostic network. To date, design and planning of diagnostic networks in LMICs has largely been driven by infectious diseases such as TB and HIV, relying on manual methods and expert consensus, with a limited application of data analytics. Recently, there have been efforts to improve diagnostic network planning, including diagnostic network optimization (DNO). The DNO process involves the collection, mapping, and spatial analysis of baseline data; selection and development of scenarios to model and optimize; and lastly, implementing changes and measuring impact. This review outlines the goals of DNO and steps in the process, and provides clarity on commonly used terms.

Indexed as

data analyticsdiagnostic network optimizationlow- and middle-income countries

Identifiers

PMID33374315
PMCPMC7823670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.